Evidence map›Paper›PMID 22116359›Full record

ArticleCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology2011

Identification of allelic variants of pendrin (SLC26A4) with loss and gain of function.

Silvia Dossena, Aigerim Bizhanova, Charity Nofziger, Emanuele Bernardinelli, Josef Ramsauer, Peter Kopp, Markus Paulmichl

Open access · bronzeAbstract read
In one paragraph

Article in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Molecular Features of SLC26A4 Common Variant p.L117F.Journal of clinical medicine · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Iodide excess regulates its own efflux: a possible involvement of pendrin.American journal of physiology. Cell physiology · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Silvia DossenaInstitute of Pharmacology and Toxicology, Paracelsus Medical University, Salzburg, Austria.
Aigerim Bizhanova
Charity Nofziger
Emanuele Bernardinelli
Josef Ramsauer
Peter Kopp
Markus Paulmichl
Paracelsus Medical University · ATNorthwestern University · USInstitute of Pharmacology · CZ

Funding

Function and structure of pendrin in thyroid cellsR01DK063024 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KOPP, PETER ANDREAS · 2003 to 2007
$1.3M
NIDDK NIH HHS 1R01DK63024-01NIDDK NIH HHS R01 DK063024
6 · The paper itself

Abstract

backgroundPendrin is a multifunctional anion transporter that exchanges chloride and iodide in the thyroid, as well as chloride and bicarbonate in the inner ear, kidney and airways. Loss or reduction in the function of pendrin results in both syndromic (Pendred syndrome) and non-syndromic (non-syndromic enlarged vestibular aqueduct (ns-EVA)) hearing loss. Factors inducing an up-regulation of pendrin in the kidney and the lung may have an impact on the pathogenesis of hypertension, chronic obstructive pulmonary disease (COPD) and asthma. Here we characterize the ion transport activity of wild-type (WT) pendrin and seven of its allelic variants selected among those reported in the single nucleotide polymorphisms data base (dbSNPs), some of which were previously identified in a cohort of individuals with normal hearing or deaf patients belonging to the Spanish population.

methodsWT and mutated pendrin allelic variants were functionally characterized in a heterologous over-expression system by means of fluorometric methods evaluating the I(-)/Cl(-) and Cl(-)/OH(-) exchange and an assay evaluating the efflux of radiolabeled iodide.

resultsThe transport activity of pendrin P70L, P301L and F667C is completely abolished; pendrin V609G and D687Y allelic variants are functionally impaired but retain significant transport. Pendrin F354S activity is indistinguishable from WT, while pendrin V88I and G740S exhibit a gain of function.

conclusionAmino acid substitutions involving a proline always result in a severe loss of function of pendrin. Two hyperfunctional allelic variants (V88I, G740S) have been identified, and they may have a contributing role in the pathogenesis of hypertension, COPD and asthma.

Indexed as

AllelesGenetic VariationAmino Acid SequenceAmino Acid SubstitutionAnionsAsthmaCell LineDatabases, GeneticHumansHypertensionIon TransportMembrane Transport ProteinsMolecular Sequence DataMutationPolymorphism, Single NucleotidePulmonary Disease, Chronic ObstructiveAnionsMembrane Transport ProteinsSLC26A4 protein, humanSulfate Transporters

Identifiers

PMID22116359
PMCPMC3709191
OpenAlexW2086624002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.